vimarsana.com
Home
Live Updates
Tigermed Reports 2022 Interim Result with Strong Financial G
Tigermed Reports 2022 Interim Result with Strong Financial G
Tigermed Reports 2022 Interim Result with Strong Financial Growth
/PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated...
Related Keywords
Shanghai ,
China ,
Hong Kong ,
United Kingdom ,
Shenzhen ,
Guangdong ,
Suzhou ,
Jiangsu ,
Vietnam ,
Republic Of ,
Wuhan ,
Hubei ,
Hangzhou ,
Zhejiang ,
Chinese ,
Tigermed Pharmacovigilance ,
Asia Pacific ,
Xiaochun Cao ,
International Financial Reporting Standards ,
Research Largest Language Service Providers Ranking ,
Stock Exchange ,
Tigermed Regulatory Affairs ,
Lab Services ,
Prnewswire Hangzhou Tigermed Consulting Co Ltd ,
Clinical Service Market ,
Shenzhen Stock Exchange ,
Human Genetic Resource Administration Of China ,
Clinical Trial Solutions ,
Medical Translation ,
Chinese Mainland ,
Largest Language Service Providers ,
Data Management ,
Statistical Analysis ,
Site Management ,
Clinical Trial Sites ,
Clinical Service ,
Human Genetic Resource Administration ,
Branding Positioning ,
Tigermed ,